News
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
Currently, only liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are approved for weight loss, though some other GLP-1 drugs may be prescribed off-label. Keep in mind ...
In the Phase 3 test, which included over 1,400 participants, the overall occurrences of liver trouble were in line with other weight-loss drugs that have already been approved. However ...
Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results